Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT
NCT04504318
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Venous Thromboembolism
Interventions
DRUG:
Apixaban 2.5 MG Oral Tablet
DRUG:
Enoxaparin 40Mg/0.4mL Prefilled Syringe
Sponsor
Stanford University